Ep. 106: Yaron Brook: Capitalism, Ayn Rand, and the Moral Case for Freedom

About this episode

Yaron Brook discusses the moral and philosophical foundations of capitalism and Ayn Rand's philosophy of Objectivism.

Yaron Brook, chairman of the Ayn Rand Institute and host of the Yaron Brook Show, joins Niklas to discuss the moral and philosophical foundations of capitalism. They explore Ayn Rand’s philosophy of Objectivism, the ethical case for individual freedom, and why capitalism is often misunderstood in modern political discourse. The conversation also touches on libertarian governance, free private cities, and what a truly free society could look like in practice. A deep dive into capitalism, philosophy, and the future of human freedom. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com

People in this episode

Host: Niklas

Guest: Yaron Brook

Topics covered

• capitalism
• Ayn Rand
• Objectivism
• individual freedom
• libertarian governance
• free private cities
• philosophy

Keywords

• capitalism
• Ayn Rand
• Objectivism
• individual freedom
• libertarian governance
• free private cities
• philosophy

Mentioned in this episode

Organizations: Ayn Rand Institute

Books & works: Yaron Brook Show

More episodes of Stranded Technologies Podcast

• Ep. 110: Tomas Pueyo & Trey Goff On The Next Silicon Valley Might Be A New Country · June 4, 2026 · 2h 27m
• Ep. 109: Jonathan Anomaly on The Future of Human Enhancement, Genetic Selection & Startup Societies · May 21, 2026 · 1h 22m
• Ep. 108: The Buck Inst. President, Eric Verdin, on Pathways to Life Extension Acceleration: Alternative Pathways and Radical Hopium vs. Scientific Realism · May 8, 2026 · 46 min
• Ep. 107: Sid Sijbrandij On Beating Cancer with First Principles, n = 1 Personalized Treatments and Special Access Regulatory Pathways · April 10, 2026 · 47 min
• Ep. 105: Andrew Hessel: Programming DNA and Engineering the Future of Life · February 20, 2026 · 1h 6m
• Ep. 104: Ruxandra Teslo: Clinical Trials, Drug Innovation, and the Bottleneck to Biotech Abundance · February 20, 2026 · 1h 3m